Pfizer 1 XNB (Inlyta 1 mg)
Generic Name: axitinib
Pill with imprint Pfizer 1 XNB is Red, Elliptical / Oval and has been identified as Inlyta 1 mg. It is supplied by Pfizer Inc..
Inlyta is used in the treatment of renal cell carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Inlyta 1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer 1 XNB
Inlyta
- Generic Name
- axitinib
- Imprint
- Pfizer 1 XNB
- Strength
- 1 mg
- Color
- Red
- Size
- 9.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0145
- Inactive Ingredients
-
microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, magnesium stearate, titanium dioxide, triacetin, ferric oxide red, hypromellose 2910 (15000 mPa.s)
Note: Inactive ingredients may vary.
Related Images for "Pfizer 1 XNB"
More about Inlyta (axitinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: multikinase inhibitors
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
